logical deficits have appeared. However, with few articles on large patient numbers, little statistical data exist to aid patient counseling in their preoperative decision process, assessing long-term effects of surgery and risks for permanent morbidity.
In 1994, a study on 100 intramedullary tumors was published, emphasizing the recommendation of surgery on intramedullary tumors early and identifying syringomyelia as a factor predicting their resectability. 50 As patients with intramedullary tumors were continuously added to the spinal cord database since 1991, this paper can now present a detailed analysis of patients with intramedullary tumors treated between 1980 and 2012. Since 1991 all patients were entered into the database continuously. Apart from general patient data and specific features of each spinal cord pathology, the neurological examinations before surgery, before discharge from the hospital, 3 months postoperatively, and yearly thereafter were analyzed for individual symptoms according to a scoring system 31 (Table 1 ) and the modified McCormick Scale 40, 41 (Table 2) . Among these 1317 patients, 278 presented with intramedullary tumors. Unless a patient appeared unfit to undergo an operation, surgery was recommended to all symptomatic patients presenting with an intramedullary tumor de novo. In patients with recurrent tumors after a previous operation, surgery was restricted to patients with evidence of tumor growth or progressive neurological symptoms. Fifty-three patients were either advised against another operation or declined surgery. A total of 225 patients underwent surgery and form the basis of this study. These patients underwent a total of 246 operations on 250 tumors.
Before the introduction of MRI, the diagnosis was based on CT scanning with contrast or myelography in 8 patients, while the diagnoses were based on MRI findings in the remainder.
Cervical tumors were treated with the patient in the semisitting position, and all other tumors were treated with the patient in a prone position. The exposure involved laminotomies with reinsertion of the lamina for children, while laminectomies were used for adults up to the mid-1990s when laminae were reinserted with increasing frequency in adults as well. Since 1995 all laminae were reimplanted. The microsurgical technique used was based on the work of Malis 37 and Stein and McCormick 57 and has been published in detail previously. 32 It was general practice to demonstrate the exact extension of the tumor with ultrasonography before myelotomy. Tumors affecting only one side of the spinal cord were approached via the dorsal root entry zone. All other tumors were removed via a midline approach. The spinal cord was opened over the entire tumor before debulking of the tumor was begun. All proliferating tumors were debulked before the plane toward the spinal cord was dissected.
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The only exceptions from this strategy applied to angioblastomas, which were removed in toto, and lipomas, which were decompressed only to a degree to allow a sufficient untethering of the cord. 28, 32 After GTR or STR, the cord was closed with pia sutures (since 1995).
Before discharge every patient was examined neurologically. Control MR images before discharge have been ordered routinely since the early 1990s. After discharge from the hospital, all surgically treated patients were examined after 3 months including MRI at that time, and yearly follow-up information was obtained by further outpatient visits or questionnaires.
Three types of tumors were distinguished: Type A (displacing tumors) comprising ependymomas, angioblastomas, cavernomas, metastases, melanocytomas, dermoid cysts, meningiomas, and neuromas (n = 162); Type B (infiltrating tumors) comprising astrocytomas and gangliogliomas (n = 80); and Type C (nonproliferating tumors) comprising lipomas (n = 8).
According to the amount of resection, the following categories were distinguished: a GTR was defined as no tumor remnant detectable at the end of surgery or on postoperative MRI. An STR was defined as a complete resection of the tumor mass with a small remnant detectable on the postoperative MRI. A PR was defined as an incomplete resection of the tumor mass. Operations with less than 50% reduction in the tumor mass were classified as biopsies.
The 241 operations were divided among 20 neurosurgeons. Three groups of surgeons were distinguished according to the number of operations performed: Group A surgeons performed fewer than 20 operations (16 surgeons, 52 operations); Group B surgeons performed between 20 and 30 operations (2 surgeons, 44 operations); and Group C surgeons performed more than 70 operations (2 surgeons, 150 operations).
The study period was divided into operations performed prior to 1990 (Period A, n = 67), from 1991 to 2000 (Period B, n = 92), and from 2001 to 2012 (Period C, n = 87).
According to their age at surgery, patients were divided into 3 groups: patients in Age Group A were 20 years or younger (n = 33); those in Age Group B were between 21 and 60 years (n = 181); and those in Age Group C were 61 years or older (n = 32).
For statistical tests of significance, Student t-tests and chi-square tests were used. Means are given with the standard deviation. Surgical morbidity was defined as a permanent aggravation or a new, permanent deficit of motor function, gait, or sphincter function within 30 days after the operation. Sensory functions, dysesthesias, and pain were analyzed separately. A postoperative neuropathic pain syndrome was defined as postoperative neuropathic pain requiring medication. A postoperative myelopathy was defined as a neurological deterioration in the absence of tumor growth or tumor recurrence. Long-term followup was analyzed with Kaplan-Meier statistics 26 to determine the percentages of patients with tumor recurrences. Differences were considered statistically significant if a p value ≤ 0.05 was reached. For all statistical analyses the software package "PC-Statistik" version 5.0 was used (Hoffmann-Software).
Results

Preoperative Data
A total of 278 patients were encountered. The mean age at clinical presentation was 41 ± 17 years (range 3 weeks to 83 years) with an average clinical history of 33 ± 45 months. (Table 4) . This trend, however, was not accompanied by a decrease of the average preoperative history (33 ± 41 months, 23 ± 28 months, and 42 ± 60 months for patients in Periods A, B, and C, respectively).
Management
A total of 225 patients underwent 246 operations on 250 tumors. Table 5 provides an overview about the histologies and operations that were performed. The average follow-up for patients who underwent surgery was 41 ± 53 months. In every patient, GTR was attempted except for spinal lipomas, which were either decompressed or partially removed. 28, 32 Looking at displacing tumors (Type A), 135 (83.3%) of 162 tumors underwent GTR (Fig. 1 In a multivariate analysis, independent factors predicting a GTR were determined ( Table 6 ). The most important factor by far was a high preoperative McCormick grade. Other strong predictors were adult age, a high spinal level, presence of a syrinx, and first surgery on the tumor. The remaining factors predicting a GTR were benign histological grade, no arachnoid scarring, a short preoperative history, and an experienced surgeon.
Short-Term Outcome
Complications were encountered in 39 operations (15.9%) ( (Table 8 ). This resulted in a permanent loss of a grade on the modified McCormick Scale for 16.1%. For Type A and B tumors, surgical morbidities showed no statistical difference, while no permanent morbidity was observed for Type C tumors, as these were treated by decompression or limited resection only (difference not significant). Looking at the different groups of surgeons, morbidity declined significantly with growing experience. Likewise, morbidity tended to decline continuously throughout the study period (difference not significant). No statistical differences were detected between different age groups even though morbidity for patients older than 60 years (Age Group C) was almost twice as high compared with adults in Age Group B.
Permanent morbidity correlated significantly with the preoperative status of the patient as exemplified by preoperative McCormick grades or walking abilities. The lowest morbidity was associated with McCormick Grades I and II and for patients walking without aids. Surgery on 189 tumors for patients who were able to walk with or without aids resulted in a permanent loss of walking abilities for 13.8% (25.8%, 13.3%, and 11.7% for surgeons of Groups A, B, and C, respectively; p = 0.048). Although not statistically significant, morbidity was lowest after GTR compared with STR or PR. There was no difference for tumors associated with a syrinx compared with those without syringomyelia. Permanent morbidity varied considerably among different histological grades (27.3% for ependymomas, 18.4% for astrocytomas, 7.7% for cavernomas, and 3.6% for angioblastomas). The highest permanent morbidity rate was observed for ependymomas treated by Group A surgeons (41.2%).
According to a multiple regression analysis, independent risk factors for permanent surgical morbidity were tumor hemorrhages, limited surgical experience, a benign histological grade, and surgery on a recurrent tumor ( Table 9 ).
The postoperative clinical results for the first 12 months are presented in Table 10 . As a general rule, the individual scores declined postoperatively to improve again to preoperative levels toward the end of the 1st postoperative year except for sensory function, which recovered only to a limited degree in that time. This pattern was not detected for Type C tumors. Their scores tended to improve with surgery as long as retethering did not lead to new clinical problems. Scores for malignant tumors tended to deteriorate toward the end of the 1st postoperative year. Overall, 74.8% of patients kept their preoperative McCormick grade, while 9.1% exhibited an improvement. 
Long-Term Outcome
Long-term analyses of clinical recurrence rates are listed in Table 11 . For Type A tumors, the overall recurrence rate after 10 years was 11.8%. For Type B tumors, this figure was determined as 40.9% (p = 0.025, log-rank test). In Type C tumors, long-term results correlated with the rate of retethering. If malignant tumors were excluded from Types A and B, the figures changed to 12.0% for Type A and 27.1% for Type B after 10 years (p = 0.025, log-rank test). Tumors associated with syringomyelia demonstrated significantly lower recurrence rates than those without a syrinx (16.7% and 28.7% after 10 years, respectively; p = 0.029, log-rank test). There was no influence of age on recurrence rates (23.2% for Age Group A, 21.9% for Age Group B, and 17.5% for Age Group C after 10 years).
Looking at individual histologies, the recurrence rate for intramedullary ependymomas was determined as 5.1% after 10 years, with all recurrences occurring within the first 2 years after surgery. The recurrence rate correlated with the amount of tumor resection.
The overall recurrence rate for astrocytomas was 42.6% after 10 years. The rates correlated with the histological grade and the amount of tumor resection. For benign astrocytomas, the recurrence rate was 6.3% after GTR or STR within 10 years, whereas partially resected or biopsied tumors recurred at a rate of 42.5% in that period (p = 0.031, log-rank test). The recurrence rates after PR and biopsies were identical for benign astrocytomas.
Six of the 28 angioblastomas recurred. Among patients with VHL disease, 4 of 14 recurrences were observed compared with 2 recurrences in 14 patients without VHL disease. Due to limited numbers, this difference was not statistically significant. The 2 recurrences in patients without VHL disease were related to one STR early in the study, while the other patient developed an extramedul- lary recurrence after resection of a giant angioblastoma that had grown through the entire cord, splitting it into 2 halves. No recurrences were observed after removal of intramedullary cavernomas. After resection of 3 dermoid cysts, 4 lipomas, and 4 patients with a combination of lipoma and dermoid cyst, 2 recurrences were observed for dermoid cysts. Additional neurological deteriorations occurred in 2 patients late after surgery for lipomas related to retethering.
Long-Term Morbidity-Neuropathic Pain
Apart from tumor recurrences, the quality of life after surgery for an intramedullary tumor may be compromised by a neuropathic pain syndrome or postsurgical myelopathy.
A neuropathic pain syndrome was observed after 21.9% of operations and always started a few weeks or months after the operation (Fig. 3) . Table 12 lists rates for such pain syndromes for different subgroups. For Type A tumors, 25.6% were affected (ependymomas 31.3%, angioblastomas 18.5%, and cavernomas 23.1%), 11.5% of Type B tumors (astrocytomas 12.2%), and 75% of Type C tumors (p = 0.002, chi-square test). The rate of patients affected by neuropathic pain syndromes declined during the study period from 25.8% in Period A and 30.0% in Period B to 13.1% in Period C (p = 0.024, chi-square test). This could indicate that growing surgical experience with these pathologies might have played a role, but looking at the different groups of surgeons revealed the opposite trend with the highest rates for surgeons of Group C compared with Groups B and A.
In a multivariate analysis, a high spinal level of the tumor, syringomyelia, and preoperative presence of neu- ropathic pain appeared to be the strongest predictors of a postoperative neuropathic pain syndrome. Less important factors were first surgery on a tumor and increasing age (Table 13) . Postoperative cord tethering, tumor hemorrhages, histological grade, amount of tumor resection, use of a duraplasty, or the duration of the preoperative history were not found to have an influence on the development of a neuropathic pain syndrome in this analysis.
Long-Term Morbidity-Postsurgical Myelopathy
Clinical signs of a myelopathy unrelated to a recurrent tumor growth were noted after 3.7% of operations. This phenomenon was seen almost exclusively in patients with postoperative fixation of the spinal cord to the dura and affected 5.1% of those with radiological evidence of such postoperative cord tethering compared with 1% of those without (p = 0.03, chi-square test). The amount of tumor resection or the presence of a syrinx did not have an influence in this respect. No such myelopathy was observed in a patient in whom a duraplasty had been inserted to enlarge the subarachnoid space.
Postoperative cord tethering was observed in 37.0% of postoperative MR images (Fig. 3) . Neither the number of previous operations nor the use of a duraplasty affected this rate. However, closing the spinal cord with pia sutures after GTR or STR lowered the rate of postoperative tethering from 51.7% to 19.6% (p = 0.0007, chi-square test). No syrinx developed de novo after pia closure in this series. Table 5 are in line with other series: 1, 3, 8, 20, 24, 27, 40, 52, 63 ependymomas, astrocytomas, angioblastomas, and cavernomas constitute 86.4% of the total; all other pathologies are rare. Metastases, 21, 45 melanocytomas, 18,25 intramedullary neuromas, 5, 48 and meningiomas 10, 49 are unusual intramedullary lesions mostly discussed as case reports in the literature.
Discussion
Since the first intramedullary tumor of this series was surgically treated in 1980, diagnostic methods have improved with the introduction of MRI and intraoperative ultrasonography, intraoperative neurophysiological monitoring became available, and the surgeons involved gained more and more experience in removing these challenging lesions. With introduction of the spinal cord database in 1991, patients were entered and monitored continuously up to the present time.
Preoperative Data
Throughout the study period the preoperative neu- 2.5 ± 1.1 2.3 ± 1.1 2.9 ± 0.7 3.8 ± 0.5 6 mos 2.7 ± 1.1 2.3 ± 1.2 2.9 ± 0.7 3.8 ± 0.5 1 yr 2.7 ± 1.1 2.3 ± 1.2 2.6 ± 1.0 3.8 ± 0.5 dysesthesia preop 3.9 ± 0.9 4.1 ± 0.9 3.9 ± 0.9 4.6 ± 0.9 postop 4.0 ± 0.9 4.1 ± 0.9 4.3 ± 0.5 4.8 ± 0.5 3 mos 3.9 ± 0.9 4.1 ± 0. 3.7 ± 1.3 3.2 ± 1.7 2.9 ± 1.4 4.0 ± 0.7 gait ataxia preop 3.7 ± 1.1 3.2 ± 1.6 2.9 ± 1.6 4.2 ± 0.5 postop 2.7 ± 1.5 2.6 ± 1.3 2.6 ± 1.4 4.0 ± 0.7 3 mos 3.2 ± 1.5 2.9 ± 1.4 3.0 ± 1.5 4.2 ± 0.5 6 mos 3.4 ± 1.5 3.2 ± 1.6 2.9 ± 1.5 4.2 ± 0.5 1 yr 3.4 ± 1. rological conditions steadily improved as indicated by higher McCormick grades in Period C compared with Periods B and A (Table 4 ). This can be attributed to improving imaging techniques and the wider accessibility of MRI scanners. Patients are more likely to undergo MRI for less severe symptoms nowadays than they were in the 1980s or 1990s. It has become exceptional that an intramedullary tumor is diagnosed only after the patient has become unable to walk and is wheelchair dependent. Surprisingly, however, this development has not led to a significantly shorter history before patients presented. However, a trend in this direction was detectable: in Period A, 39% presented with a history of up to 1 year; in Periods B and C, this rate rose to 52% and 55%, respectively. The spinal level of the tumor also showed an impact on the preoperative neurological condition (Table 3) . Cervical tumors tended to produce more dysesthesias but less pain, motor deficits, or gait or sphincter disturbances compared with tumors in the thoracic cord or conus. Sensory dysfunction, on the other hand, affected all tumor localizations alike. The larger size of the cervical compared with the thoracic cord could be an explanation for this effect as tumors had to reach a larger size to produce more severe neurological deficits.
Resection Results
As far as the preoperative assessment of the resectability of an intramedullary tumor is concerned, steadily improving imaging standards for T2-weighted images demonstrate with increasing accuracy, whether an infiltrating or displacing tumor can be expected. Likewise, an associated syrinx was an indicator of a displacing and, thus, a removable tumor. 50 However, one can never be certain in an individual case. Whether a GTR is possible remains to be an intraoperative decision. Only the characteristic MRI features of cavernomas, angioblastomas, and lipomas 32 allowed a precise preoperative diagnosis in this study.
Except for lipomas, surgery was always intended as a GTR. A resection of the tumor mass was always possible at least for benign tumors in Types A and B. With increasing experience, the rate of GTRs increased significantly in this study. It is widely accepted that tumors that displace spinal cord tissue can be removed completely with microsurgical techniques. These tumors were analyzed as Type A in this study and accounted for 66% of the total. Overall, 83.0% and axial (E) contrast-enhanced T1-weighted images with contrast show no tumor recurrence or remnant, a further decrease of the syrinx, and tethering of the cord to the dura posteriorly. The patient's postoperative neurological course was characterized by a significant worsening of motor functions and gait followed by an incomplete recovery, leaving the patient wheelchair dependent. Three months after surgery, her neuropathic pain syndrome started to become considerably aggravated. of these tumors underwent GTR 7, 17, 19, 20, 27, 34, 37, 44, [56] [57] [58] 63 with a significant and steady increase of this rate throughout the study period. The corresponding learning curve was evident for the entire department as well as for individual surgeons. Whereas less than two-thirds of these tumors underwent GTR in the 1980s or by surgeons with a limited experience of less than 20 operations, this rate has increased to 98.3% since 2000.
Infiltrating tumors, on the other hand, cannot be removed radically without risking significant damage to the spinal cord. Astrocytomas are the most common tumors analyzed as Type B. In this study, GTR was achieved in 20.5%, with great variability of reported rates for GTRs in the literature. 4, 19, 20, 27, 37, 53, [56] [57] [58] 63 Malignant tumors of Type B could never be removed completely. For benign tumors, on the other hand, GTR could be obtained with increasing frequency similar to the improving results for Type A tumors. Since 2000, about two-thirds of these tumors underwent either GTR or STR.
The major reasons for the increasing rates of GTR and STR appear to be the improvements in preoperative imaging with MRI as well as in the intraoperative visualization with ultrasonography, the introduction of small ultrasonic aspirators, and increasing experience. With better pre-and intraoperative demonstration of the tumor extension, removal of the mass is easier. It is recommended to open the spinal cord over the entire tumor extension before starting the removal. 56, 57 Continuous debulking is an important technical step to achieve a GTR. Quite often, the tumor becomes better demarcated from normal cord tissue once a considerable amount is removed. With partial devascularization during debulking, the tumor becomes more distinguishable from the surrounding spinal cord tissue, and dissection planes may appear that were not apparent at the beginning. If a syrinx accompanied the tumor, tumor margins could be more easily defined as the syrinx had separated cord and tumor tissue from each other, particularly at the upper and lower tumor margins. This explains the higher GTR rates for tumors with syringomyelia. Dissecting the tumor off the spinal cord tissue and identifying tumor feeders for coagulation and transection were the last steps of the removal, 32,37,57 with one important exception: angioblastomas, which were easy to recognize due to their orange color and usual position in the dorsal root entry zone, were removed in toto and were not debulked to avoid major bleeding. 6, 19, 32, 37, 38, 56, 57, 64 As most of the angioblastomas were surrounded by a syrinx, dissecting the lesion out of the spinal cord did not pose significant problems in most instances.
Trying to dissect the plane between tumor and spinal cord right at the beginning of the operation, however, will often lead to the false impression that a dissection plane does not exist. 56, 57 This was likely a major reason for lower GTR rates by less experienced surgeons in this study. Performing a biopsy and decompression in such instances is not sufficient (Fig. 2) .
A GTR of intramedullary lipomas, which have no proliferating potential, was never attempted. 19, 37 Therefore, these lesions were analyzed as the third separate Type C. In almost all patients, neurological symptoms were not related to the lipoma but to spinal cord tethering. Therefore, debulking was performed only in patients in whom the lipoma was involved in the tethering process. Otherwise, only a decompression with a duraplasty was performed. 28, 32 The multivariate analysis disclosed a number of independent factors predicting a GTR. The preoperative neurological status as classified in the McCormick grade was by far the most important factor. Slow-growing, dis- placing tumors can be expected to produce severe neurological deficits later compared with infiltrating or fastergrowing neoplasms. This may also explain why adult age and a syrinx were found to predict a GTR, as children harbor infiltrating tumors more often than adults and syringomyelia was a more common feature of displacing tumors. Similarly, a short preoperative history for benign tumors and a benign histological grade were factors making a GTR more likely.
To summarize the different aspects influencing resection results for intramedullary tumors, an early diagnosis before severe deficits have developed and the referral to a neurosurgeon experienced with these rare pathologies are the 2 key points for optimal patient management. This not only applies to achieve a GTR but also to limit postoperative morbidity.
Postoperative Morbidity
Complications such as postoperative hemorrhages and problems related to wound healing or infections were observed at a rate of 15.8% and treatable without long-term sequelae provided they were managed appropriately and in time. Cerebrospinal fluid fistulas were the most common complication. These fistulas may be avoided using a tight running suture of the dura and tight sutures of the muscular layers, which appear to be the strongest barriers against CSF. In patients undergoing a second operation on a tumor, muscles may be atrophic from the previous operation and may no longer provide a good barrier against CSF. In such instances, placing a prophylactic lumbar drain for 1 week may be used to prevent a CSF leak. Lamina dislocations were seen early in the series when laminae were reinserted with sutures. No such instance has occurred since titanium miniplates have been used for this purpose.
The great majority of patients experienced a worse neurological status as soon as they awoke from anesthesia. This immediate postoperative worsening involved sensory functions for almost all patients, 19, 38, 39, 57 but could also affect motor power, walking abilities or sphincter control. Apart from postoperative sensory dysfunctions, 61% of the patients in this series experienced a postoperative worsening of motor functions, gait, or sphincter control. For 41.5% of patients, this deterioration was transient but for 19.5% it was permanent. These postoperative changes of sensory and other neurological functions have to be mentioned to every patient before surgery.
Postoperative Sensory Dysfunctions
Postoperative sensory deficits are an almost inevitable consequence of the myelotomy required to reach an intramedullary tumor. The longitudinal extent and, thus, the length of the myelotomy were found to correlate with postoperative sensory dysfunctions in several studies. 11, 17, 58 The only tumors that could be removed without inflicting sensory disturbances were those that had reached the pia mater, displacing all cord tissue to either side as they grew. In such cases, resections required no separate myelotomy and the tumor could be entered directly. This applied to most angioblastomas, 6, 38, 44, 57 some cavernomas, 35, 36, 55 and a few astrocytomas. Whenever the spinal cord had covered the intramedullary tumor completely, sensory functions suffered permanently to some degree. 34, 39 Apart from impaired sensations for light touch, temperature, and pain, which may render patients vulnerable to unnoticed injuries, specific problems related to impaired joint position sense may arise for elderly patients in particular.
If the cord has to be opened to gain access to the lesion, some technical steps are recommended to limit damage to sensory pathways. Obviously, monitoring of somatosensory evoked potentials may aid the surgeon in preserving sensory functions and is highly recommended. It will not only help to preserve sensory functions but also indicate how an individual tumor can and should be handled throughout the remaining operation. In a sense, monitoring sensory functions can be used to learn intraoperatively how to proceed further, once the anterior parts of the tumor are to be removed and motor functions are at risk. Neglecting somatosensory evoked potential monitoring thinking that sensory potentials cannot be preserved anyway unnecessarily gives away this chance to become acquainted with a particular tumor and its relation to the spinal cord before the most important and dangerous parts of the resection begin.
Apart from monitoring, choosing the best spot for opening the spinal cord is another important factor. If the tumor has grown predominantly on one side shifting the midline of the cord to the other, it is recommended that the myelotomy be performed in the dorsal root entry zone on the affected side. In that way, sensory functions on the other side can be spared. On the other hand, if one has to deal with a midline tumor, the myelotomy should be performed exactly in the anatomical midline along the medial posterior raphe of the spinal cord, which separates the posterior tracts from either side. To identify the exact position of the anatomical midline, surface vessels of the cord should be examined carefully. In the anatomical midline, small vessels can be followed from either side as they converge into the cord along this septum. 39, 57 Dorsal column mapping may also be used to define this midline and was associated with reduced postoperative morbidity for sensory functions in a recent report. 43 Once the spinal cord has been opened over the entire extension of the tumor, pial retention sutures should be used to minimize further surgical manipulations of sensory tracts during tumor removal. 19, 39 These sutures should only be applied after the entire tumor is visible to avoid undue tension on sensory tracts.
These technical steps may reduce sensory dysfunction to some degree, but they will not avoid them altogether. During the postoperative course, some improvement of sensory symptoms did take place. However, in the great majority this recovery was incomplete and ended within 3 months after surgery (Table 10) .
19,57
Transient Surgical Morbidity
For this study, surgical morbidity was defined as a postoperative worsening in motor power, gait, or sphincter function irrespective of postoperative changes for sensory functions or pain. The analysis showed a trend for higher rates of postoperative transient morbidity with increasing age. 20, 60 Children tended to recover more quickly compared with more advanced age groups. 60 This can be explained by the loss of spinal cord plasticity and a more vulnerable vascular supply of the cord with growing age.
Transient postoperative neurological deterioration was more common after GTRs than PRs and after operations by Group C (experienced) surgeons, who were more likely to remove a tumor completely. Therefore, transient morbidity appeared to be related to dissection along the tumor boundaries and indicated that tumor removal had been pursued as far as safely possible. The time for recovery from such transient neurological worsening was quite variable and required intensive, professional rehabilitation and active training by the patient. As a general rule, a favorable neurological outcome in this study was characterized by a neurological status similar to the preoperative level once the patient had recovered from surgery with rehabilitation. This recovery required up to 5 months for the majority of patients, but it continued for a year or even longer in some patients. 2, 19, 34, 42 Postoperative improvements were sometimes observed, but preserving the preoperative functional state was the realistic prognosis for the great majority 19 (Table 10) .
Permanent Surgical Morbidity
The major concern of every patient before surgery is the risk of becoming paraplegic. Fortunately, this fate affected patients at a steadily decreasing rate throughout the study period given the advances in diagnostic imaging, earlier diagnosis, intraoperative monitoring, technical improvements, and growing experience. Nevertheless, this risk will never be zero. Even though most papers on surgery for intramedullary tumors mention rates for postoperative improvement, unchanged status, or worsening, few articles go into such detail as to report the risk of becoming permanently wheelchair dependent.
According to the definition of permanent surgical morbidity given above, an overall rate of 19.5% was determined. Most publications report similar rates. A nationwide survey in France on surgical results for intramedullary tumors determined a rate of 18%.
1 Other studies published rates up to 34.6%: Garcés-Ambrossi et al. 20 reported a rate of 20%, Matsuyama et al. 40 a rate of 31.5%, Sandalcioglu et al. 52 a rate of 34.6%, and Manzano et al. 39 a rate of 17.9%. Fischer and Brotchi 19 documented a postoperative decline on the McCormick Scale after 1 year for 19% of patients after surgery. At that time point, 13.7% of their 131 patients who could walk before surgery had lost their walking ability. By comparison, the rate of 13.8% determined after 189 operations in patients able to walk before surgery in this study is almost identical.
Looking at permanent morbidities for individual tumor types, Aghakhani et al.
2 gave a figure of 13.9% for ependymomas, Liang et al. 35 of 6.2% for cavernomas, Lu and Lawton 36 of 9% for cavernomas, Mehta et al. 44 of 4% for angioblastomas, and Van Velthoven et al. 59 of 0% for angioblastomas. In this study, rates for permanent morbidity also varied according to histology and were lowest for angioblastomas and cavernomas but highest for ependymomas similar to these literature reports. The lower morbidity rates for cavernomas and angioblastomas can be explained by the protective effects of the gliotic capsule and the syrinx surrounding a cavernoma or an angioblastoma, respectively. Ependymomas, on the other hand, require more dissection inside the spinal cord; major tumor feeders arise from the anterior spinal artery and require isolation, coagulation, and transection before the tumor can be removed. This part of the dissection may lead to injury to or undue tension on the anterior spinal artery. The distinction between spinal cord and ependymoma tissue is usually not the major problem during dissection, so that vascular injuries appear to be the likeliest cause for permanent morbidity associated with ependymomas. Astrocytomas, on the other hand, do not pose such a precarious vascular supply but tend to infiltrate normal cord tissue. Permanent morbidity after resection of these tumors probably indicates that functional cord tissue was damaged during dissection. In any case, maintaining a sufficient blood pressure throughout the microsurgical dissection cannot be overemphasized.
So far, to my knowledge no analysis exists in the literature to determine risk factors for permanent morbidity. Several factors were found to influence morbidity significantly ( 57 mentioned the conus area as a particularly vulnerable region. This may be explained by the more vulnerable blood supply of the thoracic compared with the cervical cord and the tight concentration of important neurological functions in the small confined space of the conus. However, this relationship between spinal level and morbidity was not found in a study on 102 patients by Karikari et al. 27 This discrepancy may be explained by differences in patient positioning. In this series, all cervical tumors were treated with the patient in the semisitting position, whereas Karikari et al. 27 used the prone position for all their patients. The semisitting position allows one to visualize the entire microsurgical field at all times by simple irrigation. No suction inside the cord is necessary to identify tumor feeders or follow dissection planes. Thus, fewer manipulations inside the cord and less bipolar coagulation in particular are required for tumor removal.
Most of all, however, surgical morbidity was related to the preoperative neurological status. Once patients required walking aids, morbidity increased from 14.4% to 34.0% in this study (Fig. 3) . This is one of the strongest arguments to recommend surgery early. A watch-andwait policy cannot be supported for patients with intramedullary tumors. 2, 7, 17, 19, 34, 52, 61 The higher morbidity associated with tumor hemorrhages can be explained by difficulties distinguishing a gliosis, which is formed around hematomas, from tumor and normal spinal cord tissue. Removing such gliotic tissue almost inevitably results in neurological deficits. In situations of a fresh intramedullary bleeding, it is wisest not to attempt a complete tumor resection in the acute phase. It is recommended to just evacuate the hematoma and wait for recovery before removing the tumor.
The data analysis also demonstrated a significant influence of surgical experience on permanent surgical morbidity and the risk of becoming wheelchair dependent similar to its influence on GTR rates. The permanent morbidity rate declined significantly over the years. This again emphasizes that intramedullary tumors should be removed by neurosurgeons who perform these operations on a regular basis and have achieved sufficient experience in their management. Apart from these separate analyses for the influence of individual aspects on permanent morbidity, a multivariate analysis to determine independent risk factors of permanent surgical morbidity was undertaken ( Table 9 ). In addition to limited surgical experience and tumor hemorrhages, permanent morbidity was increased with removal of recurrent tumors as a second operation always dealt with a much more vulnerable spinal cord. As no GTR was achieved and attempted in malignant tumors, permanent morbidity was lower for these operations compared with surgery on benign tumors.
Even though several trends of the morbidity analysis did not reach statistical significance, they are worthy for comment. Surprisingly, morbidity was identical whether displacing or infiltrating tumors were surgically treated. Furthermore, morbidity was not higher for patients undergoing a GTR than those with incomplete removals. 34, 40 Patients older than 60 years had almost twice as high permanent morbidity than younger patients. Similar to the higher rate for transient deteriorations after surgery for elderly patients, the loss of spinal cord plasticity may be responsible for this effect.
Tumor Recurrences
This study as others before has demonstrated that recurrence rates depend on the histological grade and the amount of tumor resection (Table 11) . Tumors with syringomyelia demonstrated lower recurrence rates than those without, as the former were more likely to undergo a GTR.
50 Age did not demonstrate a significant influence on recurrence rates even though Type B tumors, which were less likely to undergo a GTR, were more common in children than in adults.
The influence of the histological grade on recurrence rates and patient survival is well established 4, 19, 27 and self-explanatory. Malignant tumors almost always recurred 19 except for some anaplastic astrocytomas, 27 which remained clinically silent even without adjuvant therapy. This raises the question of the reliability of the histological criteria for classification of anaplastic astrocytomas of the spinal cord. Do they really predict an aggressive behavior in every case so that adjuvant therapies including radiotherapy and chemotherapy should be instituted in every patient with anaplastic astrocytomas? It is beyond the scope of this paper to answer this question. However, discussions with pathologists disclosed significant difficulties to classify some of these astrocytomas. As nicely as debulking can be performed with small ultrasonic aspirators, this technique obviously reduced the amount of tissue available for diagnosis in some cases. However, a limited amount of tissue was not the only problem. Even when the entire tumor was sent for diagnosis, problems remained even after consulting reference centers. It appeared that if in doubt, pathologists tended to classify a tumor as Grade III rather than Grade II. From this experience, I recommend that the nature of the tumor classification in an individual patient be discussed with the pathologist. The pathologist should receive clinical information as to the duration of the preoperative history, how quickly symptoms changed, and so forth. Then the diagnostic safety or uncertainty in an individual patient can be discussed, and a recommendation for immediate or a delay of radiotherapy and chemotherapy can be given. As a general rule, radiotherapy was recommended for all Grade IV tumors and for Grade III tumors with a preoperative history of less than 6 months. Chemotherapy was not recommended but was left to the oncologists and patients to decide.
Analyzing individual histologies, a complete resection of an ependymoma was a curative operation in this study. 7, 19, 20, 34 The same applied to other benign Type A tumors. For infiltrating Type B tumors, complete as well as STR were followed by a very low recurrence rate for benign tumors.
27,53
The influence of the extent of tumor resection on outcome for ependymomas is well established. 7, 19, 20, 34 For benign astrocytomas, however, this correlation is less clear from the literature. This association has been reported in some publications, 27,53 but Garcés-Ambrossi at al. 20 could not demonstrate such a correlation between extent of resection and progression-free survival for astrocytomas. This may be explained by rather low patient numbers in most studies and even smaller numbers of patients undergoing GTR. 4 Given the fact that all but 2 angioblastomas were removed completely and in toto, the rather high rate of recurrences was surprising. In VHL, a recurrence may develop anytime and anywhere in the spinal canal. 44 For patients without VHL, however, no recurrence should be observed after a complete resection. The 2 recurrences in this study could be attributed to an incomplete resection in one case and an extramedullary recurrence on the ventral side of the cord in the other after resection of a giant angioblastoma penetrating the cord completely.
Dermoid cysts may recur whenever the capsule is not completely resected, as was the case in 2 patients in this study. Removal of dermoid cysts may be facilitated by a gliotic rim around its capsule similar to the gliosis around cavernomas. However, if the often irritating contents of a ruptured dermoid cyst have caused severe arachnoid scarring or a recurrent dermoid has to be removed, a GTR may be impossible to achieve. Fischer and Brotchi 19 operated on 2 intramedullary epidermoid and dermoid cysts, each leaving part of the capsule in place to prevent spinal cord damage. Whether recurrences occurred was not mentioned. Sharma et al. 54 emphasized the association with other dysraphic features in these patients, which may also require management. The relevance of spinal cord tethering on the management of dermoid cysts and lipomas has been the subject of another analysis of the spinal cord database in a recent report.
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Late Complications
The clinical long-term outcome of patients with intra-medullary tumors does not depend on tumor recurrences and immediate postoperative morbidities alone. Even patients who underwent a complete resection of a benign tumor and made a very gratifying neurological recovery may suffer from significant neuropathic pain syndromes or develop a severe myelopathy at a later stage.
In this study, 3.7% of patients developed a postsurgical myelopathy, which usually started a few months after surgery. This late complication was observed almost exclusively in patients with MRI evidence of postoperative tethering of the spinal cord to the dura. 22 Similar to other cord tethering diseases-spinal dysraphism, 28 posttraumatic, 29 postinfectious, or posthemorrhagic arachnopathies 30 -impairments of oxidative metabolism and spinal cord blood flow appear to be responsible. 62 Such tethering was determined on 37.0% of postoperative MR images (Figs. 2 and 3) . In other words, just about 10% of patients with radiological features of cord tethering became affected by a myelopathy. Similarly, only a minority of patients with spina bifida and radiological signs of retethering become symptomatic and require a subsequent untethering operation.
9,51
The incidence of postoperative tethering could be reduced significantly with pial sutures, whereas duraplasties had no protective effect in this respect unlike observations after other operations aiming to untether the cord or to establish a patent subarachnoid space. [28] [29] [30] 51 However, no cord tethering became symptomatic in a patient with a duraplasty. Goto et al. 22 likewise limited postsurgical tethering by combining pial suturing with a duraplasty. Therefore, pial sutures are recommended after GTR or STR and never led to syrinx formation as has concerned Kucia et al. 34 Duraplasty should be considered for surgery on recurrent tumors.
So far, no operations have been performed aiming to untether a cord in a patient with a postoperative myelopathy. Such attempts are not without risks. After all, the spinal cord is not only adherent to the dura but is also atrophic and, thus, very vulnerable to vascular injuries during untethering. Such untethering operations should therefore be reserved for patients with a progressive deterioration of gait and should be seen as a last chance to avoid wheelchair dependency.
Neuropathic pain syndromes are the other late postoperative complication that may appear a few weeks to months after surgery. 19, 42, 47, 56, 57 A total of 21.9% of patients were affected in this study. McGirt et al. 42 observed a rate of 19% for children, and Fischer and Brotchi 19 reported long-term pain syndromes in 37.4%. These differences in reported rates may be explained by different criteria to determine such a pain syndrome. In this study, a neuropathic pain syndrome was diagnosed if the patient experienced a neuropathic type of pain to a degree that a medication regimen for a prolonged period was required.
Neuropathic pain syndromes are common in patients with syringomyelia of any cause whenever the syrinx affects the posterior horns rather than the central part of the cord. 46 Therefore, it is no surprise that a syrinx associated with a tumor was found to be a strong predictor for this complication in a multivariate analysis (Table 13) . However, syringomyelia is not the only factor involved. Displacing tumors appeared to be more commonly involved than infiltrating tumors (Table 12) . A high spinal level also predisposed to this late complication in the present study, as did growing age 42 and the preoperative presence of neuropathic pain. 42 Postoperative cord tethering was not a factor predisposing to this syndrome. Similarly, the amount of resection and the experience of the surgeon did not play independent roles, suggesting that this complication may not be related to the surgery itself.
A Japanese study reported a higher overall rate of postoperative neuropathic pain syndromes of 60% and a particularly high rate for angioblastomas, 47 which is the tumor type with the highest rate for an associated syringomyelia. Another study in children determined a rate for neuropathic pain syndromes of 65% with a long preoperative history, increasing age, and severe immediate postoperative neurological deficits as independent predictors. 42 Lu and Lawton 36 found dysesthetic pain syndromes to be more common in patients with a longer preoperative history of symptoms and determined a rate of 23% for cavernomas.
Overall, the precise mechanism of this late complication and how it may be avoided remain obscure and open for speculation. Interestingly, the frequency of this syndrome decreased considerably in the past 10 years in this series. This may be a consequence of the early prescription of medications such as gabapentin and pentagabalin nowadays, which were not available in the 1980s or 1990s.
Conclusions
The great majority of intramedullary tumors are benign, slow-growing neoplasms. This study confirms the recommendation of early surgery before severe neurological deficits have developed. Surgery on these tumors is risky and even a complete removal of a benign tumor with an initially favorable outcome may still be followed by severe clinical problems limiting the quality of a patient's life. The results of this study demonstrate that a GTR is possible for the majority of benign intramedullary tumors and associated with low recurrence rates. To achieve this goal with a low morbidity rate, early diagnosis and treatment are as important as sufficient experience of the surgeon. This study also found a considerably better prognosis for cervical tumors compared with other spinal levels.
Late morbidity was commonly observed in the form of neuropathic pain syndromes and rarely as a postoperative myelopathy. Such pain syndromes were found in cervical tumors and those associated with syringomyelia in particular and appeared to be unrelated to surgical maneuvers or experience. Postoperative myelopathies were related to cord tethering and could be prevented by limiting postoperative arachnoid scar formation by pial sutures after tumor removal.
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